These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 26149222)

  • 21. Counseling Patients with a Glioblastoma Amenable Only for Subtotal Resection: Results of a Multicenter Retrospective Assessment of Survival and Neurologic Outcome.
    Coburger J; Segovia J; Ganslandt O; Ringel F; Wirtz CR; Renovanz M
    World Neurosurg; 2018 Jun; 114():e1180-e1185. PubMed ID: 29621607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.
    Lau D; Hervey-Jumper SL; Han SJ; Berger MS
    J Neurosurg; 2018 May; 128(5):1410-1418. PubMed ID: 28731401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudoprogression in glioblastoma patients: the impact of extent of resection.
    Park HH; Roh TH; Kang SG; Kim EH; Hong CK; Kim SH; Ahn SS; Lee SK; Choi HJ; Cho J; Kim SH; Lee KS; Suh CO; Chang JH
    J Neurooncol; 2016 Feb; 126(3):559-66. PubMed ID: 26608521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1.5-T Field Intraoperative Magnetic Resonance Imaging Improves Extent of Resection and Survival in Glioblastoma Removal.
    Marongiu A; D'Andrea G; Raco A
    World Neurosurg; 2017 Feb; 98():578-586. PubMed ID: 27838425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-grade glioma surgery in eloquent areas: volumetric analysis of extent of resection and its impact on overall survival. A single-institution experience in 190 patients: clinical article.
    Ius T; Isola M; Budai R; Pauletto G; Tomasino B; Fadiga L; Skrap M
    J Neurosurg; 2012 Dec; 117(6):1039-52. PubMed ID: 23039150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial impact of high-field intraoperative magnetic resonance imaging on the efficacy of pediatric low-grade glioma surgery.
    Roder C; Breitkopf M; Ms ; Bisdas S; Freitas Rda S; Dimostheni A; Ebinger M; Wolff M; Tatagiba M; Schuhmann MU
    Neurosurg Focus; 2016 Mar; 40(3):E13. PubMed ID: 26926053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma.
    Quick-Weller J; Lescher S; Forster MT; Konczalla J; Seifert V; Senft C
    Br J Neurosurg; 2016 Jun; 30(3):313-7. PubMed ID: 26743016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Intra-operative MRI (iMRI) in Improving Extent of Resection and Survival in Patients with Glioblastoma Multiforme.
    Khan I; Waqas M; Shamim MS
    J Pak Med Assoc; 2017 Jul; 67(7):1121-1123. PubMed ID: 28770902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. γ knife surgery versus reoperation for recurrent glioblastoma multiforme.
    Skeie BS; Enger PØ; Brøgger J; Ganz JC; Thorsen F; Heggdal JI; Pedersen PH
    World Neurosurg; 2012 Dec; 78(6):658-69. PubMed ID: 22484078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma.
    De Bonis P; Fiorentino A; Anile C; Balducci M; Pompucci A; Chiesa S; Sica G; Lama G; Maira G; Mangiola A
    Clin Neurol Neurosurg; 2013 Jul; 115(7):883-6. PubMed ID: 22959214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping.
    Schucht P; Beck J; Abu-Isa J; Andereggen L; Murek M; Seidel K; Stieglitz L; Raabe A
    Neurosurgery; 2012 Nov; 71(5):927-35; discussion 935-6. PubMed ID: 22895402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma.
    Randolph DM; McTyre ER; Paulsson AK; Holmes JA; Hinson WH; Lesser GJ; Strowd R; Lo HW; Laxton AW; Tatter SB; Debinski W; Chan MD
    Clin Neurol Neurosurg; 2016 Dec; 151():73-78. PubMed ID: 27816029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.
    Gulati S; Jakola AS; Nerland US; Weber C; Solheim O
    World Neurosurg; 2011 Dec; 76(6):572-9. PubMed ID: 22251506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
    Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
    J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.
    Rahman M; Abbatematteo J; De Leo EK; Kubilis PS; Vaziri S; Bova F; Sayour E; Mitchell D; Quinones-Hinojosa A
    J Neurosurg; 2017 Jul; 127(1):123-131. PubMed ID: 27689459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.
    Berkmann S; Schlaffer S; Nimsky C; Fahlbusch R; Buchfelder M
    J Neurosurg; 2014 Nov; 121(5):1166-75. PubMed ID: 25127413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
    Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
    J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggressive repeat surgery for focally recurrent primary glioblastoma: outcomes and theoretical framework.
    Sughrue ME; Sheean T; Bonney PA; Maurer AJ; Teo C
    Neurosurg Focus; 2015 Mar; 38(3):E11. PubMed ID: 25727220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgery.
    Shah AS; Sylvester PT; Yahanda AT; Vellimana AK; Dunn GP; Evans J; Rich KM; Dowling JL; Leuthardt EC; Dacey RG; Kim AH; Grubb RL; Zipfel GJ; Oswood M; Jensen RL; Sutherland GR; Cahill DP; Abram SR; Honeycutt J; Shah M; Tao Y; Chicoine MR
    J Neurosurg; 2021 Aug; 135(2):505-514. PubMed ID: 33035996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.